BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 12351399)

  • 1. Mechanisms of CD47-induced caspase-independent cell death in normal and leukemic cells: link between phosphatidylserine exposure and cytoskeleton organization.
    Mateo V; Brown EJ; Biron G; Rubio M; Fischer A; Deist FL; Sarfati M
    Blood; 2002 Oct; 100(8):2882-90. PubMed ID: 12351399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial dysfunction in CD47-mediated caspase-independent cell death: ROS production in the absence of cytochrome c and AIF release.
    Roué G; Bitton N; Yuste VJ; Montange T; Rubio M; Dessauge F; Delettre C; Merle-Béral H; Sarfati M; Susin SA
    Biochimie; 2003 Aug; 85(8):741-6. PubMed ID: 14585540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD47 ligation induces caspase-independent cell death in chronic lymphocytic leukemia.
    Mateo V; Lagneaux L; Bron D; Biron G; Armant M; Delespesse G; Sarfati M
    Nat Med; 1999 Nov; 5(11):1277-84. PubMed ID: 10545994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caspase-independent type III programmed cell death in chronic lymphocytic leukemia: the key role of the F-actin cytoskeleton.
    Barbier S; Chatre L; Bras M; Sancho P; Roué G; Virely C; Yuste VJ; Baudet S; Rubio M; Esquerda JE; Sarfati M; Merle-Béral H; Susin SA
    Haematologica; 2009 Apr; 94(4):507-17. PubMed ID: 19278964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD47 signals T cell death.
    Pettersen RD; Hestdal K; Olafsen MK; Lie SO; Lindberg FP
    J Immunol; 1999 Jun; 162(12):7031-40. PubMed ID: 10358145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD99 signals caspase-independent T cell death.
    Pettersen RD; Bernard G; Olafsen MK; Pourtein M; Lie SO
    J Immunol; 2001 Apr; 166(8):4931-42. PubMed ID: 11290771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD47 engagement inhibits cytokine production and maturation of human dendritic cells.
    Demeure CE; Tanaka H; Mateo V; Rubio M; Delespesse G; Sarfati M
    J Immunol; 2000 Feb; 164(4):2193-9. PubMed ID: 10657674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD47 agonist peptides induce programmed cell death in refractory chronic lymphocytic leukemia B cells via PLCγ1 activation: evidence from mice and humans.
    Martinez-Torres AC; Quiney C; Attout T; Boullet H; Herbi L; Vela L; Barbier S; Chateau D; Chapiro E; Nguyen-Khac F; Davi F; Le Garff-Tavernier M; Moumné R; Sarfati M; Karoyan P; Merle-Béral H; Launay P; Susin SA
    PLoS Med; 2015 Mar; 12(3):e1001796. PubMed ID: 25734483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mechanism of CD47-dependent killing of T cells: heterotrimeric Gi-dependent inhibition of protein kinase A.
    Manna PP; Frazier WA
    J Immunol; 2003 Apr; 170(7):3544-53. PubMed ID: 12646616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tethering of apoptotic cells to phagocytes through binding of CD47 to Src homology 2 domain-bearing protein tyrosine phosphatase substrate-1.
    Tada K; Tanaka M; Hanayama R; Miwa K; Shinohara A; Iwamatsu A; Nagata S
    J Immunol; 2003 Dec; 171(11):5718-26. PubMed ID: 14634079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrin-associated protein/CD47 regulates motile activity in human B-cell lines through CDC42.
    Yoshida H; Tomiyama Y; Ishikawa J; Oritani K; Matsumura I; Shiraga M; Yokota T; Okajima Y; Ogawa M; Miyagawa Ji; Nishiura T; Matsuzawa Y
    Blood; 2000 Jul; 96(1):234-41. PubMed ID: 10891456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Farnesyltransferase inhibitor BMS-214662 induces apoptosis in B-cell chronic lymphocytic leukemia cells.
    Marzo I; Pérez-Galán P; Giraldo P; López-Royuela N; Gómez-Benito M; Larrad L; Lasierra P; Rubio-Félix D; Anel A; Naval J
    Leukemia; 2004 Oct; 18(10):1599-604. PubMed ID: 15356656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD47 ligation induces a rapid caspase-independent apoptosis-like cell death in human monocytes and dendritic cells.
    Johansson U; Higginbottom K; Londei M
    Scand J Immunol; 2004 Jan; 59(1):40-9. PubMed ID: 14723620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor activity of a monoclonal antibody against CD47 in xenograft models of human leukemia.
    Uno S; Kinoshita Y; Azuma Y; Tsunenari T; Yoshimura Y; Iida S; Kikuchi Y; Yamada-Okabe H; Fukushima N
    Oncol Rep; 2007 May; 17(5):1189-94. PubMed ID: 17390064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new disulfide-linked dimer of a single-chain antibody fragment against human CD47 induces apoptosis in lymphoid malignant cells via the hypoxia inducible factor-1α pathway.
    Sagawa M; Shimizu T; Fukushima N; Kinoshita Y; Ohizumi I; Uno S; Kikuchi Y; Ikeda Y; Yamada-Okabe H; Kizaki M
    Cancer Sci; 2011 Jun; 102(6):1208-15. PubMed ID: 21401803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD40 activation does not protect chronic lymphocytic leukemia B cells from apoptosis induced by cytotoxic T lymphocytes.
    Chu P; Wierda WG; Kipps TJ
    Blood; 2000 Jun; 95(12):3853-8. PubMed ID: 10845920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drp1 mediates caspase-independent type III cell death in normal and leukemic cells.
    Bras M; Yuste VJ; Roué G; Barbier S; Sancho P; Virely C; Rubio M; Baudet S; Esquerda JE; Merle-Béral H; Sarfati M; Susin SA
    Mol Cell Biol; 2007 Oct; 27(20):7073-88. PubMed ID: 17682056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligation of centrocyte/centroblast marker 1 on Epstein-Barr virus--transformed B lymphocytes induces cell death in a reactive oxygen species--dependent manner.
    Kim YS; Park GB; Choi YM; Kwon OS; Song HK; Kang JS; Kim YI; Lee WJ; Hur DY
    Hum Immunol; 2006 Oct; 67(10):795-807. PubMed ID: 17055356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caspase-independent phosphatidylserine exposure during apoptosis of primary T lymphocytes.
    Ferraro-Peyret C; Quemeneur L; Flacher M; Revillard JP; Genestier L
    J Immunol; 2002 Nov; 169(9):4805-10. PubMed ID: 12391190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-CD20 antibody (IDEC-C2B8, rituximab) enhances efficacy of cytotoxic drugs on neoplastic lymphocytes in vitro: role of cytokines, complement, and caspases.
    Chow KU; Sommerlad WD; Boehrer S; Schneider B; Seipelt G; Rummel MJ; Hoelzer D; Mitrou PS; Weidmann E
    Haematologica; 2002 Jan; 87(1):33-43. PubMed ID: 11801463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.